Continuous glucose monitoring in primary care - are we there?

Purpose of review In this review, we examine the expanding role of continuous glucose monitoring in glycaemic management in primary care. Recent findings Improving technology and decreasing cost have increased the uptake of use of continuous glucose monitoring (CGM) for glycaemic management in primary care, wherein most diabetes is managed. Optimized use of this technology, however, will require a convergence of several factors. Availability of devices for people with diabetes, availability of data at the time of clinical interactions, and expertise in interpretation of CGM and ambulatory glucose profile (AGP) data, as well as optimization of therapies, will be required. Significant progress has been made in all three areas in recent years, yet creating systems of support for widespread use of CGM in primary care remains an area of active investigation. There has been significant uptake in the use of CGM in the management of diabetes in primary care. Optimized use, however, requires both access to CGM data and the expertise to use the data. Although promising strategies have emerged, the task of generalizing these strategies to the broad population of primary care in America is ongoing. CGM technology holds significant potential for improving glycaemic management in primary care, yet important work remains to leverage the full potential of this promising technology.

Automated summary

This review examines the expanding role of continuous glucose monitoring in glycemic management in primary care, highlighting the convergence of several factors as crucial for optimized use of this technology. While significant progress has been made in recent years in all three areas, there is still work to be done in creating systems of support for widespread use of CGM in primary care.